Lv1
30 积分 2025-12-26 加入
Current CMC challenges in oligonucleotide API development: from IND to NDA
6小时前
已完结
Small nucleic acid therapeutics: delivery breakthroughs, clinical translation, and future paradigms in precision medicine
5个月前
已完结
Now with oligos: antibody-oligonucleotide conjugates are the new drug modality to watch
6个月前
已完结
Nanobody-Oligonucleotide Conjugates (NucleoBodies): The Next Frontier in Oligonucleotide Therapy
8个月前
已完结
皖公网安备34019202002308
